Skip to main content
Explore URMC

Scott J. Cameron, Ph.D., M.D.

Contact Information

Phone Numbers

Appointment: (585) 341-7700

Fax: (585) 276-1530

Faculty Appointments

Patient Care Setting



Dr. Cameron cares for patients in the Coronary Care Unit as well as patients in the office who have general cardiac and vascular problems including post-heart attack care, high blood pressure and cholesterol, heart failure, valvular heart disease, aneurysms, arrhythmias and conduction disorders, syncope, peripheral arterial and venous disease. He is board certified in both Internal Medicine and Cardiovascular Disease (ABIM). He also holds voluntary board certification in General Vascular Medicine (ABVM), and he is a Registered Physician in Vascular Interpretation (APCA).

Professional Background

Dr. Cameron trained initially as a pharmacologist at the University of Edinburgh in Scotland which is his home country. He completed postgraduate training in the same discipline at the University of Rochester, then postdoctoral fellowship training in clinical chemistry at the Johns Hopkins Hospital, Department of Pathology, in Baltimore.

Dr. Cameron then qualified in medicine at Upstate Medical University in Syracuse, later serving as an internal medicine resident at the New York Presbyterian Hospital-Cornell in New York City. He finally completed a five-year integrated clinical and research fellowship in cardiology and vascular medicine at the University of Rochester. Dr. Cameron was mentored in platelet biology by Dr. Craig Morrell who is a national expert in this discipline. He initiated an innovative vascular assessment referral clinic for local optometrists called Vascular Assessment in Patients for Ocular Reasons (VAPOR). He was also the founding member of the University of Rochester Pulmonary Embolism Response Team (PERT). Dr. Cameron has a clinical and academic interest in thrombotic emergencies and presently serves on the University of Rochester faculty as a physician investigator. He serves as Associate Editor of Vascular Medicine, and he is on the editorial board of ATVB. He is a frequent peer reviewer for Circulation, Circulation Research, Journal of Clinical Investigation, American Journal of Medicine, Journal of Thrombosis and Thrombolysis, and the British Medical Journal. In addition, Dr. Cameron is a test writer for the American Board of Internal Medicine Cardiovascular Disease MOC and longitudinal assessment.

Dr. Cameron specializes in both cardiac and vascular disease with admitting privileges at Strong Memorial Hospital where he cares for patients in the Coronary Care Unit. He has documented COCATS Level II training in echocardiography, nuclear cardiology, and COCATS Level III training in vascular medicine. Dr. Cameron is board certified in Internal Medicine, Vascular Medicine, Vascular Ultrasound, and Cardiovascular Disease.


Our laboratory studies signal transduction pathways in the cardiovascular system as they relate to thrombotic and ischemic diseases. Our research focus is mostly basic and translational in nature. We are particularly interested in identifying existing and novel platelet signaling pathways in myocardial ischemia and in peripheral vascular disorders such as advanced peripheral artery disease (PAD), chronic venous insufficiency (CVI), and aortic aneurysmal disease. An overarching theme of our laboratory is personalized medicine where we aim to better define platelet function in disease states, paying close attention to post-receptor signal transduction pathways.

Platelets are small anucleate blood particles which play an important role in thrombosis, hemostasis, and inflammation. When patients are treated with anti-platelet drugs, some do not derive expected benefits or they experience off-target adverse events. We have initiated several lines of investigation that show the megakaryocyte-derived platelet phenotype may be fundamentally different in various diseases.

Project 1: Using a murine model of myocardial infarction, we have shown that platelet RNA and the platelet proteome as well as platelet agonist responsiveness are different in the post-myocardial infarct environment. A career-development grant was awarded to study the role of ERK5 and related protein kinases in changing platelet function in ischemic disease. We began enrolling patients with ST-segment elevation myocardial infarction (STEMI) and non ST-segment elevation myocardial infarction (NSTEMI) in July of 2016 to study this phenomenon immediately when the patient arrives in the emergency department at Strong Memorial Hospital.

Project 2: Using a murine model of abdominal aortic aneurysm (AAA) and, along with our colleagues in vascular surgery and cardiac surgery at the University of Rochester, we are studying platelet function both as a consequence of aortic disease and in promoting aortic disease progression. We use genetic approaches to identify platelet targets useful in modulating vascular disease.

Project 3: Using a murine model of critical limb ischemia (CLI) and various models mimicking the human condition of hypoxia, we have identified two important signal transduction mechanisms which lead to dysregulated platelet behavior. This may in part explain why patients with PAD are predisposed to heart attack and stroke. We recently extended our studies to human platelets from PAD patients with our colleagues in vascular surgery at the University of Rochester and in the Department of Pathology at the Johns Hopkins Hospital.

Project 4: It is well-documented that patients who are exposed to inhaled pollutants are predisposed to adverse cardiovascular events. Using platelets taken from patients with acute myocardial infarction, we are working with our colleagues in environmental medicine and public health at the University of Rochester to study the role of particulate matter and environmental pollutants in changing platelet function and promoting thrombosis. These studies may reveal protective mechanisms that could be employed to prevent adverse cardiac events caused by pollutants.

Project 5: Using our existing database of patients with venous thromboembolism (VTE), we are studying various clinical and translational aspect of high risk pulmonary embolism locally and as part of the National Pulmonary Embolism Response Team (PERT) consortium.

We utilize contemporary cell biology, biochemistry, molecular biology, and animal models to address these questions. Our overall goal is to evaluate gaps in clinical care, identify viable signaling pathways in human tissue for drug intervention, and then finally to utilize animal models to test the working hypothesis. We are a friendly, collaborative laboratory with continuous federal funding from 2016-2026 with a keen interest in the career development of all laboratory members.



  • Cardiovascular Disease - American Board of Internal Medicine
  • Internal Medicine - American Board of Internal Medicine


BSc (Hons) | UK-University of Edinburgh

MS | University of Rochester School of Medicine & Dentistry

PhD | University of Rochester School of Medicine & Dentistry

MD | SUNY Upstate Medical University

Post-doctoral Training & Residency

7/1/2011 - 6/30/2016
Fellowship in Cardiovascular Disease at University of Rochester Medical Center

7/1/2010 - 6/30/2011
Residency in Internal Medicine at New York Presbyterian Hospital

6/23/2009 - 6/30/2010
Internship in Internal Medicine at New York Presbyterian Hospital

6/23/2009 - 6/30/2011
Residency in Internal Medicine at Sloan-Kettering Memorial Hospital for Cancer & Allied Diseases

VIEW ALL expand_more


2019 - 2019
Outstanding Young Alumnus 2019 - Upstate Medical University
Sponsor: SUNY Upstate Medical University

K Award Grant
Sponsor: Central Society for Clinical and Translational Research

Resident Research Mentoring Award
Sponsor: University of Rochester

URMC Quality and Safety Certificate of Recognition - Pulmonary Embolism Response Team
Sponsor: Quality of Care Committee
Location: Rochester, NY

NIH K08 Career Development Award

Fellow of the Society of Vascular Medicine

Jay D. Coffman MD Young Investigator Award in Vascular Medicine (2nd Place)
Sponsor: Society of Vascular Medicine

Fellow of the American College of Cardiology

Best of AHA Abstracts
Sponsor: American Heart Association
Location: Orlando

Abstract and Travel Award, First Place
Sponsor: American College of Cardiology (NY State)

Abstract Merit Badge (top 20%)
Sponsor: International Society of Thrombosis and Hemostasis

Abstract and Travel Award (top 10%)
Sponsor: American Heart Association (ATVB)

Platelet Colloquium Career Investigator Award
Sponsor: University of Kentucky

Abstract Award (NY State), Second Place
Sponsor: American College of Cardiology

Society of Vascular Medicine Scholarship
Sponsor: Fellows Vascular Conference Scholarship

2013 - 2019
Sponsor: National Institute of Health

Postdoctoral Research Award (1st place)
Sponsor: Aab CVRI Scientific Advisory Board

2011 - 2012
Multiple "Strong Star" nominations and Hall of Fame citation from patients and colleagues for exceptional clinical care
Sponsor: Strong Memorial Hospital/University of Rochester

Hospitalist award for best resident (honorable mention)
Sponsor: Weill-Cornell Medical Ctr.

Herbert Lourie, MD Graduation Award for gentility, thoughtfulness, philanthropy, compassion, commitment to academic excellence.
Sponsor: SUNY Upstate Medical University

Arnold Gold Humanism Honor Society for excellence in humanistic clinical care, leadership, compassion and dedication to service.

Alpha Omega Alpha Research Award – First Place
Sponsor: Podium Presenters. SUNY Upstate

American College of Physicians NY Upstate Scientific Conference: First Place
Sponsor: Medical Student Research

Distinguished Abstract Award (top 25 out of 837 selected abstracts)
Sponsor: National Academy of Clinical Biochemistry

Pathology Young Investigator's Award for excellence in basic research – highest scoring winner
Sponsor: Johns Hopkins Hospital
Location: Baltimore, Maryland

Young Investigator's Award - awarded with distinction
Sponsor: Paul E. Standjord

Pathology Young Investigator's Award for excellence in clinical research
Sponsor: Johns Hopkins Hospital
Location: Baltimore, Maryland

Dean's Award for the Most Innovative PhD Thesis
Sponsor: University of Rochester
Location: Rochester, NY

VIEW ALL expand_more


Journal Articles

Sahai A, *Bhandari B, Koupenova M, Freedman J, *Godwin M, McIntyre M, Chung M, Iskander JP, Kamran H, Hariri E, Aggarwal A, Kalra A, Bartholomew JR, McCrae KR, Elbadawi A, Svensson LG, Kapadia S, Cameron SJ. "The Effect of Aspirin on Short-term Outcomes in Hospitalized Patients with SARS-CoV-2". Vascular Medicine. 2021; .

Van Galen J, Pava L, Wright C, Elbadawi A, Chaturvedi A, Cameron SJ. "Effect of platelet inhibitors on thrombus burden in patients with acute pulmonary embolism." Platelets. 2021; 32(1): 138-140.

Chung MK, Zidar D, Bristow M, Cameron SJ, Chan T, Harding III CV, Kwon DH Singh T, Tilton J, Tsai EJ, Tucker NR, Barnard J, Loscalzo J. "Update on COVID-19 and Cardiovascular Disease: from Bench to Bedside". Circulation Research. 2021; 128(8): 1214-1236.

Books & Chapters

Chapter Title: Vascular Medicine
Book Title: Cardiology Consult Manual
Author List: Scott J. Cameron and Doran MIx
Published By: Springer 2018

Chapter Title: Pulmonary Embolism
Book Title: Cardiology Consult Manual
Author List: Hanna Mieszczanska and Scott J. Cameron
Published By: Springer 2018